The Almac Group has broadened its worldwide operation by opening a new Asia Pacific headquarters in Singapore.
The new operational facilities include primary and secondary packaging for clinical trials as well as distribution, and interactive response technology services.
The facility will allow Almac to better serve its pharmaceutical clients in Asia Pacific, either conducting regional trials or expanding to international markets as well as global clients who are carrying out pharmaceutical clinical trials in the region.
Although Almac has serviced clients in the Asia Pacific region for around 15 years this is the first time that material for clinical trials will be produced in the region, rather than being shipped from the company’s facilities in Portadown or the US.
The Singaporean regulatory body, the Health Sciences Authority (HSA) inspection of the new facility ensuring standards of safety, quality and efficacy, will make Almac the first full service clinical trial packaging and distribution organisation to ever receive GMP (Good Manufacturing Practice) certification.
The Seagoe company has said the new facility will strengthen the group’s global footprint with facilities also in Europe, the US, and satellite offices in Japan.
The Singapore facility has full-service equipment which includes primary packaging rooms, secondary packaging areas, frozen storage, label control room, a Just-in-Time (JIT) labelling suite and non-GMP storage area offering clients in the region a streamlined, personalised, turnkey solution which ultimately optimises their clinical trial.
Almac now employs more than 3,700 across its global operations including 2,300 in its Seagoe headquarters.
Last year the company announced it would invest £54m in expanding its Pharma Services and Clinical Services operations over the next five years, creating almost 350 jobs in Craigavon.